1. SLP-2 interacts with Parkin in mitochondria and prevents mitochondrial dysfunction in Parkin-deficient human iPSC-derived neurons andDrosophila
- Author
-
Andrew A. Hicks, Alessandra Zanon, Michaela Trilck, Rolf Bodmer, Valentina Giorgio, Franziska Rudolph, Christine Klein, Philip Seibler, Nancy Stanslowsky, Christine Schwienbacher, Sreehari Kalvakuri, Peter P. Pramstaller, Alexandros A. Lavdas, Marianna Guida, Anne Grünewald, Florian Wegner, Irene Pichler, Luisa Foco, Aleksandar Rakovic, Alice Serafin, Zanon A., Kalvakuri S., Rakovic A., Foco L., Guida M., Schwienbacher C., Serafin A., Rudolph F., Trilck M., Grunewald A., Stanslowsky N., Wegner F., Giorgio V., Lavdas A.A., Bodmer R., Pramstaller P.P., Klein C., Hicks A.A., Pichler I., and Seibler P.
- Subjects
Male ,0301 basic medicine ,parkinson, neuron, mitochondria ,Ubiquitin-Protein Ligases ,Induced Pluripotent Stem Cells ,Cell Culture Techniques ,Respiratory chain ,Substantia nigra ,Mitochondrion ,Biology ,medicine.disease_cause ,Parkin ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Cell Line, Tumor ,Genetics ,Cardiolipin ,medicine ,Animals ,Drosophila Proteins ,Humans ,Mitochondrial respiratory chain complex I ,Molecular Biology ,Genetics (clinical) ,Aged ,Neurons ,Mutation ,Electron Transport Complex I ,Dopaminergic Neurons ,Membrane Proteins ,Parkinson Disease ,Articles ,Blood Proteins ,General Medicine ,Middle Aged ,Mitochondria ,nervous system diseases ,Cell biology ,Substantia Nigra ,Drosophila melanogaster ,030104 developmental biology ,medicine.anatomical_structure ,chemistry ,Female ,Neuron ,Corrigendum ,030217 neurology & neurosurgery - Abstract
Mutations in the Parkin gene (PARK2) have been linked to a recessive form of Parkinson’s disease (PD) characterized by the loss of dopaminergic neurons in the substantia nigra. Deficiencies of mitochondrial respiratory chain complex I activity have been observed in the substantia nigra of PD patients, and loss of Parkin results in the reduction of complex I activity shown in various cell and animal models. Using co-immunoprecipitation and proximity ligation assays on endogenous proteins, we demonstrate that Parkin interacts with mitochondrial Stomatin-like protein 2 (SLP-2), which also binds the mitochondrial lipid cardiolipin and functions in the assembly of respiratory chain proteins. SH-SY5Y cells with a stable knockdown of Parkin or SLP-2, as well as induced pluripotent stem cell-derived neurons from Parkin mutation carriers, showed decreased complex I activity and altered mitochondrial network morphology. Importantly, induced expression of SLP-2 corrected for these mitochondrial alterations caused by reduced Parkin function in these cells. In-vivo Drosophila studies showed a genetic interaction of Parkin and SLP-2, and further, tissue-specific or global overexpression of SLP-2 transgenes rescued parkin mutant phenotypes, in particular loss of dopaminergic neurons, mitochondrial network structure, reduced ATP production, and flight and motor dysfunction. The physical and genetic interaction between Parkin and SLP-2 and the compensatory potential of SLP-2 suggest a functional epistatic relationship to Parkin and a protective role of SLP-2 in neurons. This finding places further emphasis on the significance of Parkin for the maintenance of mitochondrial function in neurons and provides a novel target for therapeutic strategies.
- Published
- 2017